1. Home >
  2. M&A >
  3. Add-on Acquisition >
  4. Spain >
  5. TiGenix N.V. Acquires Coretherapix S.L.

M&A Deal Summary

TiGenix N.V. Acquires Coretherapix S.L.

On May 5, 2011, TiGenix N.V. acquired life science company Coretherapix S.L.

Acquisition Highlights
  • This is TiGenix N.V.’s 2nd transaction in the Life Science sector.
  • This is TiGenix N.V.’s 2nd transaction in Spain.

M&A Deal Summary
Date 2011-05-05
Target Coretherapix S.L.
Sector Life Science
Buyer(s) TiGenix N.V.
Deal Type Add-on Acquisition

Target

Coretherapix S.L.

Madrid, Spain
Coretherapix S.L. engages in creation and development of stents coated medications for cardiac regeneration. The company is based in Spain.

Search 214,238 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

TiGenix N.V.

Leuven, Belgium
Category Company
Founded 2000
Sector Life Science
Revenue 6M EUR (2014)
DESCRIPTION

TiGenix N.V. is a European cell therapy company with a proprietary validated allogeneic expanded adipose-derived stem cell (eASC) platform technology for the treatment of autoimmune and inflammatory diseases, and a commercialized product. TiGenix was formed in 2000 and is based in Leuven, Belgium.

DEAL STATS #
Overall 3 of 3
Sector: Life Science M&A 2 of 2
Type: Add-on Acquisition M&A Deals 3 of 3
Country: Spain M&A 2 of 2
Year: 2011 M&A 2 of 2
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2011-05-05 Cellerix S.A.

Tres Cantos, Spain

Cellerix S.A. is a biotechnology company, engages in the development and production of medicines based on the use of stem cells of adult origin.

Buy -
Mergr

Solution for

Product

Company

Legal